Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of valerian/melissa syrup versus alprazolam on sleep quality and quality of life in chronic heart failure
IRCT201204042289N2Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of valeriana officinalis, melissa officinalis and alprazolam in chronic heart failure (CHF) and sleep disorder (2 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoints: Sleep quality and Quality of life. Started Mar 2010; status: completed.
02
Drugs
valeriana officinalismelissa officinalisalprazolam
03
Conditions
chronic heart failure (CHF)sleep disorder
Beyond the preview
Go deeper on IRCT201204042289N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201204042289N2.